$4.16
-0.21 (-4.81%)
Open$4.29
Previous Close$4.37
Day High$4.31
Day Low$4.15
52W High$5.12
52W Low$2.30
Volume—
Avg Volume53.3K
Market Cap83.39M
P/E Ratio—
EPS$-2.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+806.5% upside
Current
$4.16
$4.16
Target
$37.71
$37.71
$24.55
$37.71 avg
$48.03
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 23.69M | 23.13M | 22.16M |
| Net Income | 4.47M | 4.40M | 4.69M |
| Profit Margin | 18.9% | 19.1% | 21.2% |
| EBITDA | 8.95M | 8.70M | 7.31M |
| Free Cash Flow | 3.30M | 3.54M | 2.93M |
| Rev Growth | +11.0% | +7.8% | +15.1% |
| Debt/Equity | 0.08 | 0.09 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |